MedPath

A follow up study to evaluate the safety and effectiveness of tissue valve (aortic) among Indian patients

Not Applicable
Conditions
Health Condition 1: I358- Other nonrheumatic aortic valve disorders
Registration Number
CTRI/2022/08/044557
Lead Sponsor
SRM Institutes for Medical Science SIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient who have undergone aortic valve replacement with Edwards Inspiris Resilia

(EIR) in aortic position either of aortic stenosis/ aortic regurgitation.

2. Patient who have undergone concomitant procedure along with Aortic valve

replacement with EIR.

3. Age: Above 18 years, both genders.

4. Subject undergoing redo AVR surgery due to previous mechanical/ bioprosthetic valve

dysfunction/thrombosis (due to non-compliance to anti-coagulation medication)

5. Child-bearing age female patients planning pregnancy

6. Those who are willing to provide consent.

Exclusion Criteria

1.Infective Endocarditis

2.Paediatric and Congenital Heart Disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath